Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications
Blood Advances(2018)
摘要
Key Points Patients of minority race with myeloma have had less increase in population-level survival in the early 21st century than white patients. Data from clinical trials show that mortality is similar for minorities, suggesting the population-level difference is due to utilization.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要